Ractigen Therapeutics
Ractigen Therapeutics is a clinical stage biotech company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.
7-day free trial · no credit card
Verified contacts
16
available on Kipplo
LinkedIn employees
18
51 to 200 range
Open roles
—
no listings
Distinct roles
15
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 16 verified contacts at Ractigen Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
16 contacts with verified email or phone · masked until revealed.
- VH
Vera Huang
Senior Director, R & d, Oligonucleotide Biology · Research & Development
EmailPhone - SZ
Shawn Zhang
VP, Clinical Development · Science
EmailPhone - CY
Chris Yan
Vice President - Capital Markets and Finance · Other
EmailPhone
Showing 3 of 16 verified contacts
Top roles at Ractigen Therapeutics
15 distinct titles indexed · top 10 shown.
- 2intern
- 1associate director of pharmacology
- 1associate director, r & d
- 1co-founder, president & ceo
- 1director of innovation and partnership department
- 1head of research, associate director of neuroscience
- 1manager of administration
- 1medical director
- 1senior director, r & d, oligonucleotide biology
- 1vice president - capital markets and finance
- +5more titles
Sign up to unlock all 16 contacts at Ractigen Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 16 verified contacts at Ractigen Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.